BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 1990;5:273-87. [PMID: 2246481 DOI: 10.1177/088307389000500402] [Cited by in Crossref: 113] [Cited by in F6Publishing: 85] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Saneto RP. Alpers-Huttenlocher syndrome: the role of a multidisciplinary health care team. J Multidiscip Healthc 2016;9:323-33. [PMID: 27555780 DOI: 10.2147/JMDH.S84900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Schwabe MJ, Dobyns WB, Burke B, Armstrong DL. Valproate-induced liver failure in one of two siblings with alpers disease. Pediatric Neurology 1997;16:337-43. [DOI: 10.1016/s0887-8994(97)00030-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nat Rev Neurol 2019;15:40-52. [PMID: 30451971 DOI: 10.1038/s41582-018-0101-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 73] [Article Influence: 47.0] [Reference Citation Analysis]
4 Darin N, Oldfors A, Moslemi A, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 2001;49:377-83. [DOI: 10.1002/ana.75] [Cited by in Crossref: 207] [Cited by in F6Publishing: 107] [Article Influence: 9.9] [Reference Citation Analysis]
5 Bicknese AR, May W, Hickey WF, Dodson WE. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 1992;32:767-75. [DOI: 10.1002/ana.410320610] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 1.9] [Reference Citation Analysis]
6 Milone M, Massie R. Polymerase Gamma 1 Mutations: Clinical Correlations. The Neurologist 2010;16:84-91. [DOI: 10.1097/nrl.0b013e3181c78a89] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
7 Granata T. Metabolic and degenerative disorders. Epilepsy. Elsevier; 2012. pp. 485-511. [DOI: 10.1016/b978-0-444-52899-5.00045-9] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
8 Coughlin CR 2nd, Scharer GH, Friederich MW, Yu HC, Geiger EA, Creadon-Swindell G, Collins AE, Vanlander AV, Coster RV, Powell CA, Swanson MA, Minczuk M, Van Hove JL, Shaikh TH. Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet 2015;52:532-40. [PMID: 25787132 DOI: 10.1136/jmedgenet-2015-103049] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
9 de Laveaucoupet J, Roffi F, Audibert F, Guis F, Lacroix C, Villeneuve N, Landrieu P, Labrune P. Progressive neuronal degeneration of childhood: prenatal diagnosis by MRI. Prenat Diagn 2005;25:307-10. [DOI: 10.1002/pd.1128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 van der Knaap MS, Jakobs C, Valk J. Magnetic resonance imaging in lactic acidosis. J Inherit Metab Dis 1996;19:535-47. [PMID: 8884577 DOI: 10.1007/BF01799114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
11 Rasmussen M, Sanengen T, Skullerud K, Kvittingen EA, Skjeldal OH. Evidence That Alpers-Huttenlocher Syndrome Could Be a Mitochondrial Disease. J Child Neurol 2000;15:473-7. [DOI: 10.1177/088307380001500709] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
12 Gascon GG, Ozand PT, Cohen B. Aminoacidopathies and Organic Acidopathies, Mitochondrial Enzyme Defects, and Other Metabolic Errors. Textbook of Clinical Neurology. Elsevier; 2007. pp. 641-81. [DOI: 10.1016/b978-141603618-0.10031-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Poley JR, Nowicki MJ. Other hereditary diseases and the liver. Baillieres Clin Gastroenterol 1998;12:369-407. [PMID: 9890078 DOI: 10.1016/s0950-3528(98)90140-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
14 El Sabbagh S, Lebre AS, Bahi-Buisson N, Delonlay P, Soufflet C, Boddaert N, Rio M, Rötig A, Dulac O, Munnich A, Desguerre I. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 2010;51:1225-35. [PMID: 20196775 DOI: 10.1111/j.1528-1167.2009.02504.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.9] [Reference Citation Analysis]
15 Trevathan E. Antiepileptic Drug Development for “Therapeutic Orphans”: ANTIEPILEPTIC DRUG TRIALS FOR CHILDREN. Epilepsia 2003;44:19-25. [DOI: 10.1046/j.1528-1157.44.s7.1.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Simonati A, Filosto M, Savio C, Tomelleri G, Tonin P, Dalla Bernardina B, Rizzuto N. Features of cell death in brain and liver, the target tissues of progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher disease). Acta Neuropathol 2003;106:57-65. [DOI: 10.1007/s00401-003-0698-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
17 Schlumberger E, Dulac O. A simple, effective and well-tolerated treatment regime for West syndrome. Dev Med Child Neurol 1994;36:863-72. [PMID: 7926318 DOI: 10.1111/j.1469-8749.1994.tb11777.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
18 Ulmer S, Flemming K, Hahn A, Stephani U, Jansen O. Detection of Acute Cytotoxic Changes in Progressive Neuronal Degeneration of Childhood With Liver Disease (Alpers–Huttenlocher Syndrome) Using Diffusion-weighted MRI and MR Spectroscopy: . Journal of Computer Assisted Tomography 2002;26:641-6. [DOI: 10.1097/00004728-200207000-00030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
19 Matsumoto R, Nakano I, Shiga J, Akaoka I. Systemic lupus erythematosus with multiple perivascular spongy changes in the cerebral deep structures, midbrain and cerebellar white matter: a case report. J Neurol Sci 1997;145:147-53. [PMID: 9094042 DOI: 10.1016/s0022-510x(96)00238-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Mousson de Camaret B, Chassagne M, Mayençon M, Padet S, Crehalet H, Clerc-renaud P, Rouvet I, Zabot M, Rivier F, Sarda P, des Portes V, Bozon D. POLG exon 22 skipping induced by different mechanisms in two unrelated cases of Alpers syndrome. Mitochondrion 2011;11:223-7. [DOI: 10.1016/j.mito.2010.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
21 Goldstein A, Bhatia P, Vento JM. Update on nuclear mitochondrial genes and neurologic disorders. Semin Pediatr Neurol 2012;19:181-93. [PMID: 23245551 DOI: 10.1016/j.spen.2012.09.005] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Lim EW, Handzlik MK, Trefts E, Gengatharan JM, Pondevida CM, Shaw RJ, Metallo CM. Progressive alterations in amino acid and lipid metabolism correlate with peripheral neuropathy in PolgD257A mice. Sci Adv 2021;7:eabj4077. [PMID: 34652935 DOI: 10.1126/sciadv.abj4077] [Reference Citation Analysis]
23 Hayhurst H, Anagnostou ME, Bogle HJ, Grady JP, Taylor RW, Bindoff LA, McFarland R, Turnbull DM, Lax NZ. Dissecting the neuronal vulnerability underpinning Alpers' syndrome: a clinical and neuropathological study. Brain Pathol 2019;29:97-113. [PMID: 30021052 DOI: 10.1111/bpa.12640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Anttonen AK, Hilander T, Linnankivi T, Isohanni P, French RL, Liu Y, Simonović M, Söll D, Somer M, Muth-Pawlak D, Corthals GL, Laari A, Ylikallio E, Lähde M, Valanne L, Lönnqvist T, Pihko H, Paetau A, Lehesjoki AE, Suomalainen A, Tyynismaa H. Selenoprotein biosynthesis defect causes progressive encephalopathy with elevated lactate. Neurology 2015;85:306-15. [PMID: 26115735 DOI: 10.1212/WNL.0000000000001787] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 5.6] [Reference Citation Analysis]
25 Ferreira J, Lacson A, Raasch J, Pomerance HH. Clinico-pathologic conference: status epilepticus in a 5-year-old girl. Fetal Pediatr Pathol 2006;25:21-34. [PMID: 16754486 DOI: 10.1080/15227950600701487] [Reference Citation Analysis]
26 Hikmat O, Tzoulis C, Chong WK, Chentouf L, Klingenberg C, Fratter C, Carr LJ, Prabhakar P, Kumaraguru N, Gissen P, Cross JH, Jacques TS, Taanman J, Bindoff LA, Rahman S. The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations. Genet Med 2017;19:1217-25. [DOI: 10.1038/gim.2017.35] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
27 Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology. 2007;45:1555-1565. [PMID: 17538929 DOI: 10.1002/hep.21710] [Cited by in Crossref: 80] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
28 Sanderson KG, Millar E, Tumber A, Klatt R, Sondheimer N, Vincent A. Rod bipolar cell dysfunction in POLG retinopathy. Doc Ophthalmol 2021;142:111-8. [PMID: 32567010 DOI: 10.1007/s10633-020-09777-w] [Reference Citation Analysis]
29 Lim A, Thomas RH. The mitochondrial epilepsies. European Journal of Paediatric Neurology 2020;24:47-52. [DOI: 10.1016/j.ejpn.2019.12.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Wolf NI, Rahman S, Schmitt B, Taanman J, Duncan AJ, Harting I, Wohlrab G, Ebinger F, Rating D, Bast T. Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009;50:1596-607. [DOI: 10.1111/j.1528-1167.2008.01877.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
31 van Westrhenen A, Cats EA, van den Munckhof B, van der Salm SM, Teunissen NW, Ferrier CH, Leijten FS, Geleijns KP. Specific EEG markers in POLG1 Alpers’ syndrome. Clinical Neurophysiology 2018;129:2127-31. [DOI: 10.1016/j.clinph.2018.07.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
32 Sexton AC, Sahhar M, Thorburn DR, Metcalfe SA. Impact of a Genetic Diagnosis of a Mitochondrial Disorder 5–17 Years After the Death of an Affected Child. J Genet Counsel 2008;17:261-73. [DOI: 10.1007/s10897-007-9145-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
33 Harding BN, Alsanjari N, Smith SJ, Wiles CM, Thrush D, Miller DH, Scaravilli F, Harding AE. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults. J Neurol Neurosurg Psychiatry 1995;58:320-5. [PMID: 7897414 DOI: 10.1136/jnnp.58.3.320] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
34 Morris AAM. Mitochondrial respiratory chain disorders and the liver. Liver Int 1999;19:357-68. [DOI: 10.1111/j.1478-3231.1999.tb00063.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
35 Hikmat O, Eichele T, Tzoulis C, Bindoff LA. Understanding the Epilepsy in POLG Related Disease. Int J Mol Sci 2017;18:E1845. [PMID: 28837072 DOI: 10.3390/ijms18091845] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
36 Naviaux RK, Nguyen KV. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004;55:706-12. [PMID: 15122711 DOI: 10.1002/ana.20079] [Cited by in Crossref: 311] [Cited by in F6Publishing: 265] [Article Influence: 17.3] [Reference Citation Analysis]
37 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
38 Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC, Haas RH. Mitochondrial DNA polymerase ? deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol 1999;45:54-8. [DOI: 10.1002/1531-8249(199901)45:1<54::aid-art10>3.0.co;2-b] [Cited by in Crossref: 133] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
39 Nolte KW, Trepels-kottek S, Honnef D, Weis J, Bien CG, van Baalen A, Ritter K, Czermin B, Rudnik-schöneborn S, Wagner N, Häusler M. Early muscle and brain ultrastructural changes in polymerase gamma 1-related encephalomyopathy: Brain/muscle ultrastructure in Alpers disease. Neuropathology 2013;33:59-67. [DOI: 10.1111/j.1440-1789.2012.01317.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 McKnight CL, Low YC, Elliott DA, Thorburn DR, Frazier AE. Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned? Int J Mol Sci 2021;22:7730. [PMID: 34299348 DOI: 10.3390/ijms22147730] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
41 Smith J, Mah J, Castillo M. Brain MR imaging findings in two patients with Alpers' syndrome. Clinical Imaging 1996;20:235-7. [DOI: 10.1016/0899-7071(95)00039-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
42 Frank Y, Ashwal S. Neurologic Disorders Associated with Gastrointestinal Diseases and Nutritional Deficiencies. Swaiman's Pediatric Neurology. Elsevier; 2012. pp. 1821-66. [DOI: 10.1016/b978-1-4377-0435-8.00079-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Delonlay P, Rötig A, Sarnat HB. Respiratory chain deficiencies. Pediatric Neurology Part III. Elsevier; 2013. pp. 1651-66. [DOI: 10.1016/b978-0-444-59565-2.00033-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
44 Cardenas JF, Amato RS. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease. Semin Pediatr Neurol 2010;17:62-4. [PMID: 20434700 DOI: 10.1016/j.spen.2010.02.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
45 Van Hove JL, Lohr NJ. Metabolic and monogenic causes of seizures in neonates and young infants. Mol Genet Metab 2011;104:214-30. [PMID: 21839663 DOI: 10.1016/j.ymgme.2011.04.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
46 Pronicka E, Weglewska-Jurkiewicz A, Pronicki M, Sykut-Cegielska J, Kowalski P, Pajdowska M, Jankowska I, Kotulska K, Kalicinski P, Jakobkiewicz-Banecka J, Wegrzyn G. Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene. Med Sci Monit 2011;17:CR203-9. [PMID: 21455106 DOI: 10.12659/msm.881716] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
47 Uversky VN. Intrinsic Disorder in Proteins Associated with Neurodegenerative Diseases. In: Ovádi J, Orosz F, editors. Protein Folding and Misfolding: Neurodegenerative Diseases. Dordrecht: Springer Netherlands; 2009. pp. 21-75. [DOI: 10.1007/978-1-4020-9434-7_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Mccoy B, Owens C, Howley R, Ryan S, King M, Farrell MA, Lynch BJ. Partial status epilepticus – Rapid genetic diagnosis of Alpers’ disease. European Journal of Paediatric Neurology 2011;15:558-62. [DOI: 10.1016/j.ejpn.2011.05.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
49 Kollberg G, Moslemi A, Darin N, Nennesmo I, Bjarnadottir I, Uvebrant P, Holme E, Melberg A, Tulinius M, Oldfors A. POLG1 Mutations Associated With Progressive Encephalopathy in Childhood. J Neuropathol Exp Neurol 2006;65:758-68. [DOI: 10.1097/01.jnen.0000229987.17548.6e] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
50 Cohen BH, Naviaux RK. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 2010;51:364-73. [DOI: 10.1016/j.ymeth.2010.05.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
51 Khan A, Trevenen C, Wei XC, Sarnat HB, Payne E, Kirton A. Alpers syndrome: the natural history of a case highlighting neuroimaging, neuropathology, and fat metabolism. J Child Neurol 2012;27:636-40. [PMID: 22114215 DOI: 10.1177/0883073811423973] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
52 José da Rocha A, Túlio Braga F, Carlos Martins Maia A Jr, Jorge da Silva C, Toyama C, Pereira Pinto Gama H, Kok F, Rodrigues Gomes H. Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters. J Neuroimaging 2008;18:1-8. [PMID: 18190488 DOI: 10.1111/j.1552-6569.2007.00205.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
53 Cho JS, Kim SH, Kim HY, Chung T, Kim D, Jang S, Lee SB, Yoo SK, Shin J, Kim J, Kim H, Hwang H, Chae J, Choi J, Kim KJ, Lim BC. FARS2 mutation and epilepsy: Possible link with early-onset epileptic encephalopathy. Epilepsy Research 2017;129:118-24. [DOI: 10.1016/j.eplepsyres.2016.11.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
54 Tranebjaerg L, Jensen PK, Van Ghelue M, Vnencak-Jones CL, Sund S, Elgjo K, Jakobsen J, Lindal S, Warburg M, Fuglsang-Frederiksen A, Skullerud K. Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene. Ophthalmic Genet 2001;22:207-23. [PMID: 11803487 DOI: 10.1076/opge.22.4.207.2220] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
55 Saneto RP, Cohen BH, Copeland WC, Naviaux RK. Alpers-Huttenlocher syndrome. Pediatr Neurol 2013;48:167-78. [PMID: 23419467 DOI: 10.1016/j.pediatrneurol.2012.09.014] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
56 McKiernan P. Acute liver failure after valproate exposure: Liver transplantation may be indicated beyond childhood. Liver Transpl 2014;20:1287-9. [PMID: 25179873 DOI: 10.1002/lt.23988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
57 Uziel G, Ghezzi D, Zeviani M. Infantile mitochondrial encephalopathy. Semin Fetal Neonatal Med. 2011;16:205-215. [PMID: 21620787 DOI: 10.1016/j.siny.2011.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
58 Taanman J, Llewelyn Williams S. The Human Mitochondrial Genome. In: Berdanier C, editor. Mitochondria in Health and Disease. CRC Press; 2005. pp. 95-246. [DOI: 10.1201/9781420028843.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Frydman M, Jager-roman E, de Vries L, Stoltenburg-didinger G, Nussinovitch M, Sirota L. Alpers progressive infantile neuronal poliodystrophy: An acute neonatal form with findings of the fetal akinesia syndrome. Am J Med Genet 1993;47:31-6. [DOI: 10.1002/ajmg.1320470107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
60 Veggiotti P, Colamaria V, Dalla Bernardina B, Martelli A, Mangione D, Lanzi G. Epilepsia partialis continua in a case of MELAS: Clinical and neurophysiological study. Neurophysiologie Clinique/Clinical Neurophysiology 1995;25:158-66. [DOI: 10.1016/0987-7053(96)80168-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
61 Lake NJ, Bird MJ, Isohanni P, Paetau A. Leigh syndrome: neuropathology and pathogenesis. J Neuropathol Exp Neurol. 2015;74:482-492. [PMID: 25978847 DOI: 10.1097/nen.0000000000000195] [Cited by in Crossref: 78] [Cited by in F6Publishing: 36] [Article Influence: 11.1] [Reference Citation Analysis]
62 Decell MK, Gordon JB, Silver K, Meagher-villemure K. Fulminant hepatic failure associated with status epilepticus in children: Three cases and a review of potential mechanisms. Intensive Care Med 1994;20:375-8. [DOI: 10.1007/bf01720913] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Gilea AI, Ceccatelli Berti C, Magistrati M, di Punzio G, Goffrini P, Baruffini E, Dallabona C. Saccharomyces cerevisiae as a Tool for Studying Mutations in Nuclear Genes Involved in Diseases Caused by Mitochondrial DNA Instability. Genes (Basel) 2021;12:1866. [PMID: 34946817 DOI: 10.3390/genes12121866] [Reference Citation Analysis]
64 Muona M, Fukata Y, Anttonen AK, Laari A, Palotie A, Pihko H, Lönnqvist T, Valanne L, Somer M, Fukata M, Lehesjoki AE. Dysfunctional ADAM22 implicated in progressive encephalopathy with cortical atrophy and epilepsy. Neurol Genet 2016;2:e46. [PMID: 27066583 DOI: 10.1212/NXG.0000000000000046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
65 Uusimaa J, Hinttala R, Rantala H, Päivärinta M, Herva R, Röyttä M, Soini H, Moilanen JS, Remes AM, Hassinen IE. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus. Epilepsia. 2008;49:1038-1045. [PMID: 18294203 DOI: 10.1111/j.1528-1167.2008.01544.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
66 Oldfors A, Tulinius M. Mitochondrial encephalomyopathies. Myopathies. Elsevier; 2007. pp. 125-65. [DOI: 10.1016/s0072-9752(07)86006-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
67 Bao X, Wu Y, Wong LC, Zhang Y, Xiong H, Chou P, Truong CK, Jiang Y, Qin J, Yuan Y, Lin Q, Wu X. Alpers syndrome with prominent white matter changes. Brain and Development 2008;30:295-300. [DOI: 10.1016/j.braindev.2007.08.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
68 Gropman AL. Neuroimaging in mitochondrial disorders. Neurotherapeutics 2013;10:273-85. [PMID: 23208728 DOI: 10.1007/s13311-012-0161-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
69 Stumpf JD, Saneto RP, Copeland WC. Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol 2013;5:a011395. [PMID: 23545419 DOI: 10.1101/cshperspect.a011395] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
70 Saneto RP, Naviaux RK. Polymerase gamma disease through the ages. Dev Disabil Res Revs 2010;16:163-74. [DOI: 10.1002/ddrr.105] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
71 Rahman S. Mitochondrial disease and epilepsy. Dev Med Child Neurol 2012;54:397-406. [PMID: 22283595 DOI: 10.1111/j.1469-8749.2011.04214.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 8.8] [Reference Citation Analysis]
72 Friedman SD, Shaw DW, Ishak G, Gropman AL, Saneto RP. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev 2010;16:129-35. [PMID: 20818727 DOI: 10.1002/ddrr.103] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
73 Rahman S. Gastrointestinal and hepatic manifestations of mitochondrial disorders. J Inherit Metab Dis. 2013;36:659-673. [PMID: 23674168 DOI: 10.1007/s10545-013-9614-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
74 Park S, Kang HC, Lee JS, Park YN, Kim S, Koh H. Alpers-Huttenlocher Syndrome First Presented with Hepatic Failure: Can Liver Transplantation Be Considered as Treatment Option? Pediatr Gastroenterol Hepatol Nutr 2017;20:259-62. [PMID: 29302508 DOI: 10.5223/pghn.2017.20.4.259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Elia M, Musumeci SA, Ferri R, Colamaria V, Azan G, Greco D, Stefanini MC. Leigh syndrome and partial deficit of cytochrome c oxidase associated with epilepsia partialis continua. Brain and Development 1996;18:207-11. [DOI: 10.1016/0387-7604(95)00126-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
76 Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating Partial Seizures in Infancy: A Malignant Disorder with Developmental Arrest. Epilepsia 1995;36:1017-24. [DOI: 10.1111/j.1528-1157.1995.tb00961.x] [Cited by in Crossref: 175] [Cited by in F6Publishing: 139] [Article Influence: 6.5] [Reference Citation Analysis]
77 Hunter MF, Peters H, Salemi R, Thorburn D, Mackay MT. Alpers syndrome with mutations in POLG: clinical and investigative features. Pediatr Neurol. 2011;45:311-318. [PMID: 22000311 DOI: 10.1016/j.pediatrneurol.2011.07.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
78 Breu M, Häfele C, Glatter S, Trimmel-Schwahofer P, Golej J, Male C, Feucht M, Dressler A. Ketogenic Diet in the Treatment of Super-Refractory Status Epilepticus at a Pediatric Intensive Care Unit: A Single-Center Experience. Front Neurol 2021;12:669296. [PMID: 34149600 DOI: 10.3389/fneur.2021.669296] [Reference Citation Analysis]
79 Morris AAM, Singh-kler R, Perry RH, Griffiths PD, Burt AD, Chee Piau Wong, Gardner-medwin D, Tumbull DM. Respiratory Chain Dysfunction in Progressive Neuronal Degeneration of Childhood With Liver Disease. J Child Neurol 1996;11:417-9. [DOI: 10.1177/088307389601100517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
80 Brumback RA. The Silver Jubilee: Journal of Child Neurology Turns 25. J Child Neurol 2010;25:4-31. [DOI: 10.1177/0883073809351986] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
81 Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion 2008;8:396-413. [PMID: 18590986 DOI: 10.1016/j.mito.2008.05.003] [Cited by in Crossref: 137] [Cited by in F6Publishing: 114] [Article Influence: 9.8] [Reference Citation Analysis]
82 Garcia-Cazorla A, De Lonlay P, Rustin P, Chretien D, Touati G, Rabier D, Slama A, Saudubray JM. Mitochondrial respiratory chain deficiencies expressing the enzymatic deficiency in the hepatic tissue: a study of 31 patients. J Pediatr 2006;149:401-5. [PMID: 16939756 DOI: 10.1016/j.jpeds.2006.05.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
83 Bianchi MC, Sgandurra G, Tosetti M, Battini R, Cioni G. Brain Magnetic Resonance in the Diagnostic Evaluation of Mitochondrial Encephalopathies. Bioscience Reports 2007;27:69-85. [DOI: 10.1007/s10540-007-9046-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
84 Nguyen KV, Sharief FS, Chan SS, Copeland WC, Naviaux RK. Molecular diagnosis of Alpers syndrome. J Hepatol 2006;45:108-16. [PMID: 16545482 DOI: 10.1016/j.jhep.2005.12.026] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 5.8] [Reference Citation Analysis]
85 Walker MA, Mohler KP, Hopkins KW, Oakley DH, Sweetser DA, Ibba M, Frosch MP, Thibert RL. Novel Compound Heterozygous Mutations Expand the Recognized Phenotypes of FARS2-Linked Disease. J Child Neurol 2016;31:1127-37. [PMID: 27095821 DOI: 10.1177/0883073816643402] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
86 Nabbout R. A risk-benefit assessment of treatments for infantile spasms. Drug Saf 2001;24:813-28. [PMID: 11665869 DOI: 10.2165/00002018-200124110-00003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
87 Lee WS, Sokol RJ. Liver disease in mitochondrial disorders. Semin Liver Dis. 2007;27:259-273. [PMID: 17682973 DOI: 10.1055/s-2007-985071] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
88 Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CM, Brodtkorb E, Ostergaard E, de Coo IFM, Pias-Peleteiro L, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA. Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases. J Inherit Metab Dis 2020;43:726-36. [PMID: 32391929 DOI: 10.1002/jimd.12211] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]